by CCHR National Affairs Office | Oct 28, 2021
The psychiatric industry that profited from proliferating this drug-induced disorder will now profit from treating it. The uncontrollable muscle movement known as tardive dyskinesia (TD) is a common condition especially linked to the prolonged use of the...
by CCHR National Affairs Office | Oct 21, 2021
Depression screening can result in many false positives, leading to increased psychiatric drugging of patients. A new study is the latest to conclude that patients do not benefit from reporting on their behavior and mental health in answer to questions on depression...
by CCHR National Affairs Office | Oct 14, 2021
More than 25 million Americans taking antidepressants face withdrawal symptoms when they quit; for nearly half, the symptoms will be severe, research suggests. Millions of Americans taking psychiatric drugs are facing a risk they may be entirely unaware of: severe and...
by CCHR National Affairs Office | Sep 30, 2021
Millions of Americans are prescribed psychiatric drugs, but with no best practices for discontinuing the drugs, withdrawal symptoms can be severe. While Congress and government agencies are giving much attention to making treatment more widely available for opioid and...
by CCHR National Affairs Office | Sep 23, 2021
Human rights group calls on the Veterans Administration to add website warnings about the increased risk of suicidal thoughts and actions from antidepressants. Of the 46,510 American adults who committed suicide in 2018, one in seven was a U.S. military veteran,...
